Christine Zedelmayer - 16 Nov 2021 Form 4 Insider Report for Equillium, Inc. (EQ)

Role: Sr. Vice President and COO
Signature: /s/ Christine Zedelmayer
Issuer symbol: EQ
Transactions as of: 16 Nov 2021
Net transactions value: -$5,547
Form type: 4
Filing time: 17 Nov 2021, 14:27:36 UTC
Previous filing: 14 Jun 2021
Next filing: 07 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EQ	Common Stock	Options Exercise	$20,418	+8,334	+9.2%	$2.45	98,843	16 Nov 2021	Direct	F1
transaction	EQ	Common Stock	Sale	$22,401	-4,084	-4.1%	$5.48^*	94,759	16 Nov 2021	Direct	F2, F3
transaction	EQ	Common Stock	Options Exercise	$36,750	+15,000	+16%	$2.45	109,759	16 Nov 2021	Direct	F1
transaction	EQ	Common Stock	Sale	$40,315	-7,350	-6.7%	$5.48^*	102,409	16 Nov 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EQ	Employee Stock Option	Options Exercise	$0	-8,334	-17%	$0.000000	41,666	16 Nov 2021	Common Stock	8,334	$2.45	Direct	F4
transaction	EQ	Employee Stock Option	Options Exercise	$0	-15,000	-17%	$0.000000	75,000	16 Nov 2021	Common Stock	15,000	$2.45	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option exercises reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 17, 2021.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2021. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.59, inclusive. The reporting person undertakes to provide to Equillium, Inc., any security holder of Equillium, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4	In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or expiration dates are not considered to be of the same "class."